- Home
- AMAL vs INMD Comparison
AMAL vs INMD Comparison
Compare AMAL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMAL
- INMD
- Stock Information
- Founded
- AMAL 1923
- INMD 2008
- Country
- AMAL United States
- INMD Israel
- Employees
- AMAL N/A
- INMD N/A
- Industry
- AMAL Commercial Banks
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AMAL Finance
- INMD Health Care
- Exchange
- AMAL Nasdaq
- INMD Nasdaq
- Market Cap
- AMAL 937.6M
- INMD 887.0M
- IPO Year
- AMAL 2018
- INMD 2019
- Fundamental
- Price
- AMAL $28.81
- INMD $14.35
- Analyst Decision
- AMAL Hold
- INMD Hold
- Analyst Count
- AMAL 2
- INMD 6
- Target Price
- AMAL $33.00
- INMD $16.81
- AVG Volume (30 Days)
- AMAL 198.8K
- INMD 1.2M
- Earning Date
- AMAL 07-24-2025
- INMD 07-30-2025
- Dividend Yield
- AMAL 1.94%
- INMD N/A
- EPS Growth
- AMAL 3.73
- INMD 46.63
- EPS
- AMAL 3.34
- INMD 2.54
- Revenue
- AMAL $304,724,000.00
- INMD $401,561,000.00
- Revenue This Year
- AMAL $9.82
- INMD N/A
- Revenue Next Year
- AMAL $11.11
- INMD $5.41
- P/E Ratio
- AMAL $8.62
- INMD $5.66
- Revenue Growth
- AMAL 4.35
- INMD N/A
- 52 Week Low
- AMAL $25.03
- INMD $13.14
- 52 Week High
- AMAL $38.19
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- AMAL 42.25
- INMD 51.10
- Support Level
- AMAL $26.87
- INMD $13.79
- Resistance Level
- AMAL $29.83
- INMD $14.69
- Average True Range (ATR)
- AMAL 0.66
- INMD 0.40
- MACD
- AMAL 0.08
- INMD 0.04
- Stochastic Oscillator
- AMAL 57.06
- INMD 73.60
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.